The order rests on a small number of interconnected legal and technical concepts, which determine its scope and how it is applied.

• Declared categories. The instrument declares two legal categories: "midwifery restricted substances" (s 4, Schedule 1) and "midwifery narcotic substances" (s 5, Schedule 2). The order is classificatory; the operative language is declaratory rather than prescriptive. The order does not itself describe rights to possess, prescribe, administer or supply those substances. It simply places them within legal categories to be recognised by the regulatory regime that references the Poisons List.

• Scheduled lists. The substances are identified by name in the Schedules appended to the order. Schedule 1 lists 16 principal entries (some with lettered subentries such as 1N, 6G, 8G), including common antibiotics (for example, amoxycillin, benzylpenicillin, cephalexin), analgesics and anti‑inflammatories (ibuprofen, diclofenac), uterotonics and related agents (oxytocin, ergometrine), local anaesthetics (lignocaine), and others such as naloxone and nitrous oxide. Schedule 2 lists two specific morphine injection strengths: morphine injection 10 mg and morphine injection 15 mg.

• Interpretive reach. Clause 3 outlines how to interpret a reference to a substance in the Schedules. The list entry covers: the substance prepared from natural or artificial sources (s 3(3)(a)); plants and their parts when packed or prepared for therapeutic use except plants that are included in Schedules 8 or 9 to the Poisons List or are prohibited (s 3(3)(b)); salts, active principals and derivatives including esters and ethers and salts thereof (s 3(3)(c)); alkaloids and their salts (s 3(3)(d)); stereoisomers and their salts (s 3(3)(e)); recombinant forms (s 3(3)(f)); and any preparation or admixture containing any proportion of the substance (s 3(3)(g)). The clause also provides express exclusions, including products in Appendix A to the Uniform Standard, substances in Appendix G when below a specified concentration, and certain low‑concentration substances listed in Schedules 1 to 6 of the Poisons List (s 3(3)(h)-(j)).

• Quantitative calculation rules. Clause 3(4) prescribes how to calculate concentration, strength or quantity in applying the Poisons List. If the substance is present as a salt, active principal or derivative, the relevant amount is calculated as the equivalent of the listed substance (s 3(4)(a)). "1%" is defined as one gram per 100 millilitres for liquids and one gram per 100 grams for solids/semi‑solids (s 3(4)(b)(i)-(ii)). There is a specific rule that codeine concentrations be calculated as anhydrous codeine (s 3(4)(c)).

• Cross‑references to national standards. The instrument relies on the Uniform Standard, defined in s 3(5) as the Standard for the Uniform Scheduling of Medicines and Poisons published under the Commonwealth Therapeutic Goods Act 1989, as amended from time to time. The order uses terminology and appendices from that Uniform Standard (Appendix A and Appendix G are referenced).

• Administrative placement and commencement. The order takes effect on Gazette notification (s 2) and is administered by the Department of Health and Human Services, according to the footer of the text. The formal mechanics of publication and numbering are stated at the end of the instrument.

These concepts determine the order’s technical reach: the named substances and their variants fall into midwifery restricted or narcotic buckets; the definition clauses expand coverage to many chemical forms and preparations while carving out specified low‑concentration or Appendix‑included exclusions; and the calculation rules affect when a product is caught by the scheduling. The Uniform Standard operates as the external technical referent for exclusions and appendices.

The order itself is classificatory; it affects the legal treatment of the named substances within the broader poisons regulatory architecture. The text identifies an administering agency (the Department of Health and Human Services) and establishes designations that will be relevant to persons and entities whose activities are regulated through the Poisons List and related instruments. The order does not, within its text, itself create or change individual professional scopes, licences, or permissions, so who is directly obliged, permitted or criminally liable as a result of these declarations will depend on those other instruments and professional regulatory rules that make use of the Poisons List.

Stakeholders who should expect material impact from these entries include, by reason of the classification role the order performs:

• Regulators and administrators. The Department of Health and Human Services is named as the administering agency. Officials who enforce poisons control, interpret schedules and amend regulatory practice will use the order as a formal list for midwifery‑related scheduling.

• Professional regulators and employers. Although the order does not itself set practice rights, the classification will be relevant to health professional regulators, midwifery boards and employing organisations that adopt Poisons List classifications to determine prescribing, administration and supply rules. The order’s labels will therefore feed into any regulatory rules that tie permissions to being a "midwifery restricted" or "midwifery narcotic" substance.

• Suppliers and pharmacists. Suppliers, pharmacists and distributors who must comply with rules that reference the Poisons List will be affected because products containing the named substances (including salts, derivatives, stereoisomers and recombinant forms per s 3(3)) will be captured save for the express exclusions. The calculation rules in s 3(4) affect whether a product’s concentration brings it within schedule thresholds.

• Midwives and clinicians. Clinicians who provide maternal and perinatal care will have to consult the Poisons List, Uniform Standard and their professional regulatory instruments to determine whether these classifications affect their ability to possess, administer or supply those substances in practice. The order itself does not enlarge or restrict any practitioner’s professional authority but informs the statutory categorisation used by other rules.

• Manufacturers and importers. Producers of medicines and therapeutic preparations must consider s 3(3) and s 3(4) when determining whether their product is a "declared" substance under this order, particularly in relation to salts, derivatives, stereoisomers, recombinant forms and admixtures containing any proportion of the declared substance. The exclusion clauses in s 3(3)(h)-(j) will be material to compliance and market decisions.

• Legal advisers, compliance officers and auditors. Those charged with ensuring regulatory compliance must reconcile the order with Appendix A and Appendix G of the Uniform Standard, the Poisons List entries (Schedules 1-9), and any jurisdictional poisons legislation that attaches specific controls or penalties to the categories created by this order.

Who does not automatically gain or lose rights under this instrument: no professional scope, prescribing right or offence is created or abolished within the order’s text. Any operational effect on individual conduct derives from other instruments that rely on the Poisons List classifications created by this order. The order’s interpretive rules widen the technical reach of the named substances, so parties dealing in plants, salts, derivatives, stereoisomers, recombinant forms and admixtures must treat those forms as potentially captured unless an express exclusion in s 3(3)(h)-(j) applies.

The order is not a regulatory code of duties and rights; its operative effect is to declare certain substances as belonging to two statutory categories. It does, however, create interpretive and definitional rules that will become duties of legal interpretation for those who must apply the Poisons List or determine whether a product falls within the declared categories.

Primary declaratory duties implied by the text

• Classification duty for administrators. The administering agency (Department of Health and Human Services) must give effect to the order as a formal list of midwifery restricted and narcotic substances (s 4, s 5). The order places a legal obligation on the agency to maintain and publish the list consistent with the order’s content and to administer it in accordance with general statute practice, although the order itself does not set procedural duties.

• Interpretation duties for users. Clause 3 imposes interpretive duties on anyone determining whether a particular product or substance is captured. For example, s 3(3)(c)-(g) require that a reference to a named substance be read to include salts, derivatives, alkaloids, stereoisomers, recombinant forms and preparations containing any proportion. That is a duty to include those forms in classification unless an exclusion applies.

• Calculation duties. Clause 3(4) requires calculation of concentration, strength or quantity in a specified manner. If the substance is present as a salt, derivative or active principal, amounts are to be calculated as the equivalent amount of the listed substance (s 3(4)(a)). "1%" is operationally defined (s 3(4)(b)), and codeine is to be calculated as anhydrous codeine (s 3(4)(c)). Entities must follow those calculation rules when assessing schedule thresholds.

Express rights or permissions

• The order does not itself create permissions to possess, supply, prescribe or administer the listed substances. The text contains no express rights conferred on midwives or any other class of person. Any rights to handle the substances will arise, if at all, from other statutory or regulatory instruments that reference the Poisons List.

Notable exclusions that create rights of non‑application

• The order expressly excludes certain preparations and low‑concentration substances from the reach of a schedule entry (s 3(3)(h)-(j)). If a product meets an exclusion in Appendix A to the Uniform Standard, or is within the Appendix G concentration threshold, or is a substance included in Schedules 1-6 of the Poisons List at a concentration not exceeding 10 mg/L or 10 mg/kg (and not also included in Schedule 7 or 8), then the product will not be captured by the declared schedule entry. That exclusion functions practically as a right not to be treated as a declared substance for the purposes of the order.

Operational consequences for duties and rights

• The interpretive and calculation rules will determine, in practice, whether manufacturers, suppliers, pharmacists, clinicians and regulators must treat a product as a midwifery restricted or narcotic substance for the purposes of the broader poisons regime. Those stakeholders have a duty to consult the Poisons List and the Uniform Standard appendices referenced by s 3(3)(h)-(j) when making compliance assessments.

• Where a product contains multiple components or is an admixture, s 3(3)(g) treats any preparation containing any proportion of a named substance as falling within the entry. That creates a potentially broad capturing mechanism and a duty on compliance officers to identify trace components.

What the order does not do

• It does not set out penalties, enforcement powers, licensing conditions, record‑keeping obligations, professional scope, or criminal sanctions within its own text. Any such duties or rights associated with the declared categories will be found in other legislative instruments that rely on the Poisons List classifications. Users should not assume operational permissions or prohibitions based on the order alone; they must reconcile the order with the rest of the poisons control framework.

The order contains no express enforcement provisions, offences, penalties or investigative powers. There are no provisions turning contravention of the order into a standalone offence, and the text does not provide for inspections, seizure, licence cancellation, or penalties. The order is declaratory and classificatory in effect; it creates scheduled lists and interpretive rules, but not an enforcement apparatus within its own provisions.

Consequences for enforcement practice

• Enforcement and penalties must therefore be sought in the broader statutory and regulatory framework that makes use of the Poisons List and the Uniform Standard. The order expressly ties its scheduling mechanism to the Poisons List and the Uniform Standard (s 3(2)-(5)). Any penalties or compliance enforcement will be derived from the laws, regulations, or professional standards that incorporate the Poisons List categories. The order does not itself specify which instruments those are, beyond its cross‑references.

• Administrators and regulated parties will need to consult the Poisons List, the Uniform Standard, relevant state poisons legislation, and professional regulatory instruments to identify the applicable penalties and enforcement procedures for possession, supply, prescribing or administration of a substance declared under this order.

Implementation risk and compliance uncertainty

• The absence of enforcement details in the order creates points of implementation risk and practical uncertainty for stakeholders who must determine the legal consequences of handling a declared substance. Since the order broadens the technical reach of schedule entries (for example, to salts, derivatives, stereoisomers and recombinant forms under s 3(3)), entities may be unsure when a given preparation is caught and what penalty risk attaches until they consult the connected regulatory materials.

• The exclusions in s 3(3)(h)-(j) require cross‑checking with Appendix A and Appendix G of the Uniform Standard and Schedules 1-9 of the Poisons List. Enforcement practice may therefore turn on technical laboratory or formulation details and on the availability and interpretation of the Uniform Standard appendices, which are external to the order.

Practical note: the order records administration by the Department of Health and Human Services and the date of Gazette notification. Enforcement agencies and regulated parties should use those contacts and dates as starting points when seeking authoritative guidance on penalties, inspections and compliance processes that flow from the declared classifications.

The order is tightly cross‑referential. It does not stand alone; it operates as a classificatory adjunct to the Poisons List and the national Uniform Standard administered under the Commonwealth Therapeutic Goods Act 1989. The key textual interactions and their legal mechanics are:

• Poisons List schedules. Clause 3(2) says a reference in these regulations to a substance by name followed by "(S)" and a number is a reference to that substance when included in the correspondingly numbered Schedule to the Poisons List. The order’s schedules are therefore intended to be read alongside, and operate within, the framework of the Poisons List. The order does not replicate the Poisons List; it references it and uses its scheduling conventions.

• Uniform Standard and appendices. Clause 3(5) defines "Uniform Standard" as the Standard for the Uniform Scheduling of Medicines and Poisons published under the Commonwealth Therapeutic Goods Act 1989. Clause 3(3)(h) and (i) exclude certain preparations included in Appendix A and substances in Appendix G below specified concentrations. Consequently, the legal treatment of substances listed in this order is conditional on the contents and concentration thresholds in the Appendix materials of the Uniform Standard. This creates an operational dependency: the order’s scope expands or contracts with changes to the Uniform Standard appendices.

• Commonwealth Therapeutic Goods Act 1989. Clause 3(5) expressly ties the Uniform Standard to the Therapeutic Goods Act 1989 of the Commonwealth. The order therefore has an indirect connection to Commonwealth scheduling mechanisms, and cross‑jurisdictional interactions may arise where national scheduling changes the content of the Uniform Standard or its appendices that the order references.

• State poisons and health legislation. While the order itself contains no penalty or licensing provisions, its classifications are designed to be used by other laws that regulate possession, supply and use of scheduled substances. Those other laws are not reproduced in the order, but the order’s practical effect will depend on how state or territorial poisons legislation, health regulations, and professional practice rules incorporate the Poisons List categories.

• Product exclusions and concentration thresholds. Clause 3(3)(j) excludes substances included in Schedules 1 to 6 of the Poisons List at concentrations not exceeding 10 mg/L or 10 mg/kg unless that substance is also included in Schedule 7 or 8. This creates a direct interaction: a substance’s regulatory status under this order depends on its listing and concentration in the Poisons List schedules. Changes to the Poisons List or to appendix concentration thresholds will therefore alter the order’s practical scope.

• Amendment pathway. The order itself shows amendment markers (for example, entries in Schedule 1 marked as amended by S.R. 2016, No. 95, applied 16 Nov 2016). The presence of these annotations demonstrates that the order is subject to subsequent subordinate instrument amendments and that its practical content is updated via later statutory rules or regulations.

• Administrative interaction. The order is administered by the Department of Health and Human Services. Administrative practice, guidance, licences and compliance checks from that Department will be the primary state contact point for operationalising how the order interacts with other laws in practice.

In short, this order functions as an identification and cross‑reference device that interacts with the Poisons List, the national Uniform Standard under the Therapeutic Goods Act, and the state administrative apparatus. Its legal effects are realised only when courts, regulators, professional boards or other statutory instruments use the categories it declares as the basis for permissions, prohibitions, licensing conditions or penalties.

The order’s text contains explicit amendment annotations for a subset of Schedule 1 entries. Those annotations identify an amending subordinate instrument, S.R. 2016, No. 95, and record that the amendments were applied on 16 November 2016. The specific schedule entries that carry the bracketed note "[Schedule 1 Amended by S.R. 2016, No. 95, Applied:16 Nov 2016]" are:

• 1N. Benztropine (marked as amended).
• 6G. Clotrimazole (marked as amended).
• 8G. Domperidone (marked as amended).
• 8N. Ergometrine (marked as amended).
• 12G. Lignocaine (marked as amended).
• 14N. Naloxone (marked as amended).
• 15G. Nitrous Oxide (marked as amended).
• 15N. Nystatin (marked as amended).
• 15T. Oxytocin (marked as amended).

The schedule numbering shows both original entries and those with lettered subentries (for example, 1 and 1N) where the lettered forms indicate items added or amended later. The order does not reproduce the text of S.R. 2016, No. 95, nor does it identify the precise nature of each amendment beyond marking that the Schedule 1 entry was amended by that instrument and applied on 16 November 2016.

Other items in Schedule 1 that carry no amendment note in this text include: Amoxycillin (1), Benzylpenicillin (2), Cephalexin (3), Chloramphenicol (4), Clavulanic acid (5), Clindamycin (6), Diclofenac (7), Dicloxacillin (8), Flucloxacillin (9), Framycetin (10), Ibuprofen (11), Levonorgestrel (12), Lincomycin (13), Metoclopramide (14), Naloxone appears as 14N (amended), Nitrofurantoin (15), Ranitidine (16) and others as listed.

Schedule 2 contains two items and carries no amendment annotations within the text: Morphine injection 10 mg and Morphine injection 15 mg.

The order records its Gazette notification date as 5 January 2011. Clause 2 states that the order takes effect on the day its making is notified in the Gazette, and the statutory footer confirms the notification date. The instrument does not contain any other historical versions or a consolidated amendment table beyond the inline amendment notes.

Practical implications of the amendment history

• Users must consult not only the original order but also subsequent instruments such as S.R. 2016, No. 95 to understand the current operative text where entries are annotated as amended.

• The order’s reliance on external materials such as the Uniform Standard means that its practical content may evolve with Commonwealth adjustments to appendices or with state subordinate instrument amendments.

• The inclusion of amendment markers suggests an established amendment pathway via subordinate legislation, so stakeholders should check for later amending instruments beyond the ones identified in the order text.

The order’s text contains no references to judicial decisions, appeals, declaratory relief, or litigation involving the instrument. There are no case citations, no recorded injunctions or proceedings, and no references to judicial interpretation contained within the instrument. The schedules and clauses stand as statutory declarations without recorded litigation history in the material provided.

What this means for legal research

• The order does not, on its face, have an internal record of litigation or interpretive guidance from courts. Where legal uncertainty arises about the application of the order, researchers must seek case law that addresses the Poisons List, the Uniform Standard, or the state poisons legislation that uses the categories created by the order.

• Because the order cross‑references Commonwealth instruments and other schedules, relevant litigation is more likely to be found in cases interpreting the Uniform Standard, the Poisons List or professional scope of practice cases that concern midwifery, medicines or controlled substances. None of those cases are reproduced or referenced in the order text itself.

• Users seeking precedent or judicial construction should therefore search external databases for cases involving the Poisons List, the Uniform Standard appendices (Appendix A and Appendix G), and any challenges to subordinate instruments such as S.R. 2016, No. 95, which amended parts of Schedule 1.

In short, no litigation history is recorded in the order as provided; any judicial interpretation relevant to the order’s effect will be found outside its text.

This short order contains several technical and practical pitfalls that create compliance traps or interpretive risk if read superficially. The following points are grounded in the order’s text and should be checked by compliance officers, clinicians, manufacturers and legal advisers.

• Broad inclusions by default. Clause 3(3)(a)-(g) expands the scope of a named substance to include material prepared from natural or artificial sources; plants or parts when prepared for therapeutic use; salts, active principals, derivatives, esters, ethers; alkaloids and salts; stereoisomers and salts; recombinant forms; and any preparation or admixture containing any proportion. That language means trace amounts and variant chemical forms can be caught unless an express exclusion applies. Users should not assume that only a named chemical in its pure form is captured.

• Narrow but technical exclusions. Clause 3(3)(h)-(j) provides exclusions that may appear helpful but are technical in operation: products included in Appendix A to the Uniform Standard are excluded; substances in Appendix G are excluded when used at or below specified concentrations; and substances listed in Schedules 1-6 of the Poisons List are excluded at concentrations not exceeding 10 mg/L or 10 mg/kg unless they are also listed in Schedule 7 or 8. Those exclusions require precise cross‑referencing with external appendices and the Poisons List. A product’s exclusion depends on detailed formulation and concentration data and on whether the product is also listed in a Schedule that removes the exclusion.

• Calculation traps. Clause 3(4) prescribes calculation rules. If a substance appears as a salt or derivative, the amount is to be calculated as the equivalent amount of the listed substance, which can materially change whether a product exceeds a threshold. The definition of "1%" differs by formulation type (liquid versus solid/semi‑solid), and codeine is to be calculated as anhydrous codeine. Miscalculating equivalent amounts or misapplying the 1% rule could produce false positives or negatives as to whether a product is caught.

• Admixtures captured. Under s 3(3)(g) any preparation or admixture containing any proportion of the substance is captured. Formulators who include a declared substance as an excipient, contaminant, preservative or minor active may therefore bring the entire product within a midwifery schedule, unless an exclusion applies. This can have knock‑on effects where other laws impose different controls for scheduled substances.

• Specificity in Schedule 2. Schedule 2 lists two morphine injection strengths by concentration: 10 mg and 15 mg. This specificity means morphine injections at those strengths are declared midwifery narcotic substances. The order does not list other morphine strengths or formulations; users should not assume unlisted strengths are declared. Conversely, if other instruments (Poisons List or professional rules) reference "morphine" more broadly, the mismatch must be navigated carefully.

• Amendment annotations without text. Several Schedule 1 entries carry an annotation that they were amended by S.R. 2016, No. 95, applied 16 Nov 2016. The order does not reproduce the amending instrument. Users must check the amending instrument to know the exact nature and legal effect of those amendments. Relying on the annotated list without consulting the amending subordinate instrument risks missing substantive changes.

• No operational permissions or prohibitions in the order. Because the order is declaratory, it does not itself authorise midwives to supply, administer or possess substances listed as "midwifery restricted" or "midwifery narcotic". Practical rights and prohibitions are located in other instruments. Treating the order as a stand‑alone authority for practice would be incorrect.

• Cross‑jurisdictional dependency. The order ties to the Uniform Standard published under the Commonwealth Therapeutic Goods Act 1989 (s 3(5)). National changes to the Uniform Standard appendices or Poisons List entries could alter the effect of this state order without amendment at state level. Users should check both state and national instruments for changes.

• Administration and guidance gap. The order identifies the Department of Health and Human Services as administering agency but contains no implementation guidance, protocols or schedules for record‑keeping and monitoring. Disciplined compliance requires sourcing departmental guidance and any professional practice instruments that implement the declared categories.

To manage these gotchas, stakeholders must perform detailed formulation analyses, cross‑referencing and record‑checking against the Uniform Standard appendices, the Poisons List (Schedules 1-9) and any amending subordinate instruments such as S.R. 2016, No. 95.

Because the order is classificatory and not prescriptive, compliance for an affected party consists principally of verifying whether a product or substance is captured by the order and then taking the necessary steps mandated by the external instruments that attach legal obligations to the declared categories. The following steps, grounded in the order’s text, set out a practical compliance pathway.

1. Confirm the operative text and amendments

• Retrieve the consolidated version of the order and any amending subordinate instruments referenced in the schedule annotations, in particular S.R. 2016, No. 95 (annotated in Schedule 1 entries) and confirm their applied dates (the order records these as applied 16 November 2016). The order’s schedule annotations alone do not show the precise amendment language.

2. Cross‑reference with the Poisons List and the Uniform Standard

• Use the naming convention in s 3(2) to identify the corresponding Poisons List schedule entries. Check Schedules 1-9 of the Poisons List for overlapping entries, and examine Appendix A and Appendix G of the Uniform Standard for inclusion or concentration thresholds that determine exclusions under s 3(3)(h)-(i).
• Confirm whether any listed substance is also included in Schedule 7 or Schedule 8 of the Poisons List, which affects the exclusion in s 3(3)(j).

3. Assess product composition precisely

• Apply the inclusive definitions in s 3(3)(a)-(g) to determine whether a product’s form is captured: is the substance present as a salt, derivative, ester, ether, alkaloid, stereoisomer, recombinant form, or as any proportion of an admixture?
• Document formulation details to support an exclusion argument under s 3(3)(h)-(j) if applicable.

4. Calculate concentrations using the order’s rules

• Follow s 3(4)(a) when substances are present as salts or derivatives, converting amounts to the equivalent of the listed substance.
• Use the "1%" definitions in s 3(4)(b) for liquids and solids/semi‑solids.
• For codeine, ensure calculations are on the basis of anhydrous codeine as required by s 3(4)(c).
• Keep laboratory certificates, batch analysis and formulation data to evidence calculations.

5. Seek departmental and professional guidance

• Contact the Department of Health and Human Services for administrative guidance or published departmental policies about how the declared categories are implemented in practice.
• Consult the relevant professional regulator or midwifery board to determine whether the declared classifications affect scope of practice, prescribing permissions or record‑keeping obligations.

6. Map downstream legal obligations

• Identify the state and national laws, regulations and professional instruments that attach permissions, restrictions or penalties to the midwifery restricted and midwifery narcotic categories. Because the order contains no penalty or licensing provisions, compliance requires mapping to those external instruments and aligning procedures accordingly.

7. Update internal compliance systems

• Modify formularies, procurement checklists, storage and dispensing procedures and training materials for clinicians and pharmacists to reflect the schedule classifications and the calculation and inclusion rules in s 3.
• Ensure supply chain documentation captures whether products are excluded under Appendix A or Appendix G, and maintain evidence to support exclusion claims.

8. Monitor for changes

• Because the order ties to the Uniform Standard and the Poisons List and because it has received subordinate instrument amendments in the past (e.g. S.R. 2016, No. 95), set a monitoring regimen for changes to the Uniform Standard appendices, the Poisons List and relevant state subordinate instruments.

9. Document decision rationales

• Where a product is deemed to fall inside or outside the order’s schedules, record the factual and calculation basis, including batch analyses, conversions to equivalent substance amounts, and citations to Appendix A/G or Poisons List provisions relied upon.

10. Legal and technical review before field actions

• Before making operational changes (for example, altering which staff can administer a substance), obtain legal advice that integrates the order with the external instruments that impose duties or confer permissions, because those operational consequences do not arise from this order alone.

Checklist of immediate items to verify for a product

• Is the active ingredient named in Schedule 1 or Schedule 2?
• Is the product a plant, salt, derivative, alkaloid, stereoisomer, recombinant form or admixture containing any proportion of the listed substance (s 3(3)(a)-(g))?
• Is the product excluded under Appendix A or Appendix G of the Uniform Standard (s 3(3)(h)-(i)) or is it a low‑concentration substance in Schedules 1-6 of the Poisons List below 10 mg/L or 10 mg/kg and not listed in Schedule 7 or 8 (s 3(3)(j))?
• Have concentration conversions been done per s 3(4)(a)-(c), including treating codeine as anhydrous codeine?
• Does the product match the exact morphine injection strengths in Schedule 2 if morphine is involved?

Following these steps will align an entity’s factual assessment with the order’s definitional and calculation rules. Final operational compliance, including any permissions to possess, administer or supply, must be confirmed against the state and national legal instruments and professional practice rules that use the Poisons List categories created by this order.